Towards Mechanism-Informed Psychotherapies for Reducing Clinical Severity in Late-Life Depression: Promise and Challenges
- 21 February 2025
- journal article
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 33 (6) , 624-627
Abstract
No abstract availableFunding Information
- Advancing a Healthier Wisconsin Endowment (00003864)
- NIH
- National Institute of Mental Health (R01 MH122490)
This publication has 16 references indexed in Scilit:
- Brain Activation Associated With Response to Psychotherapies for Late-Life Depression: A Task-Based fMRI StudyThe American Journal of Geriatric Psychiatry, 2024
- Cognitive Behavioral Therapy for Late-Life Depression (CBTlate): Results of a Multicenter, Randomized, Observer-Blinded, Controlled TrialPsychotherapy and Psychosomatics, 2023
- Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric DepressionNew England Journal of Medicine, 2023
- MRI predictors of pharmacotherapy response in major depressive disorderNeuroImage: Clinical, 2022
- Comparing the streamlined psychotherapy “Engage” with problem-solving therapy in late-life major depression. A randomized clinical trialMolecular Psychiatry, 2020
- Resting State Functional Connectivity and Outcomes of Psychotherapies for Late-Life DepressionThe American Journal of Geriatric Psychiatry, 2020
- Resting-state connectivity biomarkers define neurophysiological subtypes of depressionNature Medicine, 2016
- Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and designJournal of Psychiatric Research, 2016
- Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trialThe Lancet, 2015
- Managing depression in older age: Psychological interventionsMaturitas, 2014